EyePoint Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • EyePoint Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.45M, a 105% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $32.4M, a 174% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.1M, a 15% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.2M, a 90.4% increase from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.45M, a 34.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.1M -$2.12M -15% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $14.2M +$6.73M +90.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $7.45M +$1.9M +34.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $5.55M +$979K +21.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $4.57M +$1.86M +68.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $2.7M +$248K +10.1% Jul 1, 2017 Jun 30, 2018 10-K 2020-03-16
2017 $2.46M +$293K +13.5% Jul 1, 2016 Jun 30, 2017 10-K 2020-03-16
2016 $2.16M +$202K +10.3% Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
2015 $1.96M +$550K +39% Jul 1, 2014 Jun 30, 2015 10-K 2017-09-13
2014 $1.41M +$94K +7.14% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-13
2013 $1.32M -$94K -6.66% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-10
2012 $1.41M -$641K -31.2% Jul 1, 2011 Jun 30, 2012 10-K 2013-09-27
2011 $2.05M +$557K +37.3% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-27
2010 $1.5M Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.